2 active not recruiting, 1 completed, 1 withdrawn. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Active not recruiting 1, Completed 1, Withdrawn 1 |
Follow Vibeke Backer: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| International Severe CRSwNP Registry 2024-2028 Biologic drugs - Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | Active not recruiting | Vibeke Backer | 3000 | 2025-03-31 | 2025-04-08 | |
| Mepolizumab to CRSwNP Through 12 Months - Randomised to FESS and Non-FESS Within the First 2 Weeks Mepolizumab Injection, Functional Endoscopic Sinus Surgery (FESS). - Chronic Rhinosinusitis with Nasal Polyps, Asthma | Phase 4 | Active not recruiting | Vibeke Backer | 58 | 2023-04-01 | 2025-03-30 |
| The Influence of Exercise and Hydration to the Pharmacological Response to Inhaled Terbutalin and Salbutamol in Men Exercise - Healthy | Phase 4 | Withdrawn | Vibeke Backer | 2013-11-01 | 2023-03-01 | |
| Smoking Young Asthmatics: Change of Inflammation During Tobacco Cessation and Steroid Treatment Varenicline, Placebo - Asthma | Phase 4 | Completed | Vibeke Backer | 52 | 2011-08-01 | 2020-02-05 |
Asthma (3) · Dehydration (1) · Motor Activity (1)
Biological Products (1) · Exercise (1) · Varenicline (1) · mepolizumab (1)
Denmark (3)
Vibeke B Backer, Professor (1)